Investigational Site Number :3800005

Ancona 60032

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling